1. Home
  2. TAIT vs NLSP Comparison

TAIT vs NLSP Comparison

Compare TAIT & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAIT
  • NLSP
  • Stock Information
  • Founded
  • TAIT 1989
  • NLSP 2015
  • Country
  • TAIT United States
  • NLSP Switzerland
  • Employees
  • TAIT N/A
  • NLSP N/A
  • Industry
  • TAIT Electronic Components
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • TAIT Technology
  • NLSP Health Care
  • Exchange
  • TAIT Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • TAIT 13.1M
  • NLSP 12.4M
  • IPO Year
  • TAIT 1995
  • NLSP 2021
  • Fundamental
  • Price
  • TAIT $2.26
  • NLSP $2.37
  • Analyst Decision
  • TAIT
  • NLSP
  • Analyst Count
  • TAIT 0
  • NLSP 0
  • Target Price
  • TAIT N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • TAIT 16.0K
  • NLSP 385.9K
  • Earning Date
  • TAIT 08-13-2025
  • NLSP 07-07-2025
  • Dividend Yield
  • TAIT 8.81%
  • NLSP N/A
  • EPS Growth
  • TAIT N/A
  • NLSP N/A
  • EPS
  • TAIT 0.01
  • NLSP N/A
  • Revenue
  • TAIT $4,260,000.00
  • NLSP N/A
  • Revenue This Year
  • TAIT N/A
  • NLSP N/A
  • Revenue Next Year
  • TAIT N/A
  • NLSP N/A
  • P/E Ratio
  • TAIT $232.00
  • NLSP N/A
  • Revenue Growth
  • TAIT N/A
  • NLSP N/A
  • 52 Week Low
  • TAIT $2.01
  • NLSP $1.30
  • 52 Week High
  • TAIT $3.05
  • NLSP $15.59
  • Technical
  • Relative Strength Index (RSI)
  • TAIT 49.14
  • NLSP 68.80
  • Support Level
  • TAIT $2.11
  • NLSP $2.51
  • Resistance Level
  • TAIT $2.26
  • NLSP $3.08
  • Average True Range (ATR)
  • TAIT 0.07
  • NLSP 0.21
  • MACD
  • TAIT 0.01
  • NLSP 0.04
  • Stochastic Oscillator
  • TAIT 32.00
  • NLSP 75.17

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: